Rifaximin-α: A Promising Ally in the Battle Against Alcohol-Related Liver Disease

J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101218. doi: 10.1016/j.jceh.2023.07.005. Epub 2023 Nov 22.

¹ Institute of Liver, Gastroenterology, & Pancreatico-Biliary Sciences, Sir Ganga Ram Hospital, New Delhi, India.

No abstract available

Keywords: GALA-RIF study; alcohol-related liver disease; alcoholic liver disease; gut-liver axis; liver fibrosis; rifaximin; rifaximin-α.